Survival benefit of adjuvant radiotherapy in stage III and IV bladder cancer: results of 170 patients

BACKGROUND: Radical cystectomy (RC) with or without neoadjuvant chemotherapy is the standard treatment for muscle-invasive bladder cancers. However, the locoregional recurrence rate is still significantly higher for locally advanced cases post-RC. The underuse of postoperative radiotherapy (PORT) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayoumi, Yasser, Heikal, Tarek, Darweish, Hossam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dovepress 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259260/
https://www.ncbi.nlm.nih.gov/pubmed/25506244
http://dx.doi.org/10.2147/CMAR.S69055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259260/
https://www.ncbi.nlm.nih.gov/pubmed/25506244
http://dx.doi.org/10.2147/CMAR.S69055

Ejemplares similares